Home » Topics » BioWorld Science

BioWorld Science
RSS

Gut-derived live bacterial strains found to modulate neuroinflammation and neurodegeneration in PD

May 30, 2019

TRPV1 as a novel target in gastric cancer therapy

May 30, 2019

Strep genome research expedites vaccine development

May 30, 2019

SNX29 variation plays a role in vasodilator therapy response in PAH

May 30, 2019

Polyphor, University of Zurich awarded grant to develop new class of LPS-inhibiting antibiotics

May 30, 2019

Expansion Therapeutics initiates phase I trial of ERX-963 in adults with DM1

May 30, 2019

Akero Therapeutics initiates phase IIa study of AKR-001 for the treatment of NASH

May 30, 2019

Urinary Cyr61 and TFF3 as promising new biomarkers in patients with colorectal cancer

May 30, 2019

Circulating elafin as potential new biomarker of prediabetic condition

May 30, 2019

Gallbladder cancer murine models developed from organoid cell lines

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...